Navigation Links
Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
Date:10/14/2008

TAMPA, Fla., Oct. 14 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today preliminary results from a pivotal anterior uveitis trial that compared Durezol(TM) (difluprednate ophthalmic emulsion) 0.05% dosed four times daily (QID) to Pred Forte(R) (prednisolone acetate ophthalmic suspension) 1%, dosed eight times daily. Durezol is a topical ophthalmic corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery; it was approved by the US Food and Drug Administration in June 2008. Pred Forte(R) is the registered trademark of Allergan, Inc.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO )

Ninety patients with endogenous anterior uveitis were studied in a multicenter, randomized, double-masked trial that compared the efficacy and safety of Durezol QID with Pred Forte eight times a day. Treatment for both study groups was administered for 14 days, with 2 weeks of tapering at half the dose and 2 weeks of follow-up (for a total 42 days) after initiation of therapy.

The primary endpoint was the difference from baseline in anterior chamber (AC) cell grades between the Durezol and Pred Forte groups. At Day 14, the Durezol group achieved a mean cell grade reduction of 2.1, compared to 1.9 in the Pred Forte group, confirming the noninferiority of Durezol dosed QID to Pred Forte dosed eight times a day.

"This study shows that Durezol is a potent steroid that can be used effectively four times a day to reduce inflammation in patients with moderate to severe uveitis," explained C. Stephen Foster, MD, an investigator in the trial and the founder and president of the Massachusetts Eye Research and Surgery Institution. "This is especially important since the US standard of care currently necessitates dosing steroids every hour -- and as frequently
'/>"/>

SOURCE Sirion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
2. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015   CSL ... for review a Marketing Authorization Application (MAA) for ... coagulation factor IX with recombinant albumin (rIX-FP) for ... people with Hemophilia B. Upon Swissmedic approval, rIX-FP ... treatment option with dosing intervals up to 14 ...
(Date:7/28/2015)... , July 28, 2015 VirtualScopics, Inc. ... trial imaging solutions, today announced that it will report ... p.m. ET market close on Tuesday, August 11, 2015.  ... officer, and Jim Groff , chief financial officer, ... the company,s financial results and provide a business update ...
(Date:7/28/2015)... ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) ... second quarter and year-to-date 2015 financial results on Tuesday, ... financial markets. The earnings press release will be accessible ... www.anipharmaceuticals.com . Arthur S. Przybyl ... C. Arnold , Vice President and Chief Financial Officer, ...
Breaking Medicine Technology:Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2
... Health Solutions, Inc. (NYSE: MHS ) will webcast its Annual Meeting ...  The presentations by David B. Snow Jr. , chairman and CEO, and ... , , ... Investor Relations section at www.medco.com/investor . The webcast will be available for ...
... May, AllerAir is supporting Multiple Chemical Sensitivities and Chemical Injury ...   , , , ... chemical awareness tips and a $50.00 gift certificate available via ... articles will be dedicated to Multiple Chemical Sensitivities ...
Cached Medicine Technology:Medco Announces Webcast for Annual Meeting of Shareholders 2Multiple Chemical Sensitivities Are Real 2Multiple Chemical Sensitivities Are Real 3
(Date:7/28/2015)... ... July 28, 2015 , ... By 2016, the number of smartphones worldwide ... with customers on a highly personal basis, increasing customer loyalty. However, capitalizing on this ... opportunities or lose customers to more nimble competitors. , The Open Mobile Summit 2015 ...
(Date:7/28/2015)... ... July 28, 2015 , ... Dr. Edward Buckingham and ... Sudeep Roy in July 2016. Coming to Austin from Philadelphia, Dr. Roy will ... The twelve-month long training is facilitated annually by the American Academy of Facial Plastic ...
(Date:7/28/2015)... ... July 28, 2015 , ... Representatives ... company is in full support of National Immunization Awareness Month, which is the ... stay protected against serious illnesses like the flu, measles, and pneumonia, adults need ...
(Date:7/28/2015)... ... 28, 2015 , ... Healthline , a provider of intelligent health information ... consumers’ perspectives on digital health . The survey, which was conducted among 3,679 ... digital health, level of trust in the security of digital health tools, impact of ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... embedded building blocks for edge devices that enable the Internet of Things (IoT), ... Intel® Core™ i7/i5 processor to provide exceptional computing power and multitasking capabilities. The ...
Breaking Medicine News(10 mins):Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 2Health News:Buckingham Center for Facial Plastic Surgery Welcomes Fellow 3Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3
... rise in India, hence experts say they are concerned that ... organizations compromising on quality and ethical standards while conducting drug ... of Clinical Research (ISCR), Dr. Shoibal Mukherjee has recently said ... clinical research is currently on and says that India has ...
... up its third state of the art drug ... by President A.P.J. Abdul Kalam on 16th August ... new drug // discovery research and the development ... technologies, infectious diseases, metabolism and pharmacokinetics., ,Dr ...
... during off working hours for treatment for heart attacks, ... restoration of normal blood flow, said a research // ... therapy (restoration of blood flow to an organ or ... clots) or percutaneous coronary intervention (PCI; procedures such as ...
... or those who have long working hours face increased risk ... is. Infact employees who work overtime were 61 percent ... those who didn't. ,Previous studies had established a ... certain occupations, industries or companies. It has been for the ...
... marvel. Yes! It has been proven yet another time in a ... heal young children with severe // scalding injuries. The revolutionary procedure ... for a graft. ,The skin cells that are taken from ... covering, is said to act like a “biological Band-Aid”. The fetal ...
... victim of encephalitis with, as many as 43 children and ... weeks. A report of 9 casualties has // created a ... the rush is from rural pockets around Gorakhpur, Maharajganj, Kushinagar ... special wards have been created to meet the demand and ...
Cached Medicine News:Health News:Heart Attack Patients Reaching Hospital During Off-Hours Have Increased Risk Of Death 2Health News:All Work And No Play Makes Jack A Dull Boy 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: